Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective
Dhananjay Jere, Ahmad S. Sediq, Jörg Huwyler, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 5, pp. 1900-1908
Closed Access | Times Cited: 18

Showing 18 citing articles:

Materials for Cell Surface Engineering
Kolade Adebowale, Rick Liao, Vineeth Chandran Suja, et al.
Advanced Materials (2023)
Open Access | Times Cited: 21
Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials
Federica Re, Elisa Borsani, Rita Rezzani, et al.
Gels (2023) Vol. 9, Iss. 5, pp. 389-389
Open Access | Times Cited: 20
Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations
Joshua S. Katz, Danny K. Chou, Twinkle R. Christian, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 4, pp. 919-932
Closed Access | Times Cited: 35
Transformation of Biopharmaceutical Manufacturing Through Single-Use Technologies: Current State, Remaining Challenges, and Future Development
Jasmin J. Samaras, Martina Micheletti, Weibing Ding
Annual Review of Chemical and Biomolecular Engineering (2022) Vol. 13, Iss. 1, pp. 73-97
Open Access | Times Cited: 26
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Nidhi G. Thite, Emma Tuberty-Vaughan, P. R. Wilcox, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2114-2127
Closed Access | Times Cited: 3
Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery Technologies
Susanne Page, Tarik A. Khan, Peter Kühl, et al.
The Annual Review of Pharmacology and Toxicology (2022) Vol. 62, Iss. 1, pp. 341-363
Open Access | Times Cited: 13
Image Classification of Degraded Polysorbate, Protein and Silicone Oil Sub-Visible Particles Detected by Flow-Imaging Microscopy in Biopharmaceuticals Using a Convolutional Neural Network Model
Filip M. Fedorowicz, Pascal Chalus, Kyra Kirschenbühler, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 12, pp. 3099-3108
Closed Access | Times Cited: 6
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies
Chiara Capelli, Simona Frigerio, Daniela Lisini, et al.
Cytotherapy (2022) Vol. 24, Iss. 5, pp. 544-556
Open Access | Times Cited: 10
Forced degradation of cell-based medicinal products guided by flow imaging microscopy: Explorative studies with Jurkat cells
Adam Grabarek, Wim Jiskoot, Andrea Hawe, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 167, pp. 38-47
Open Access | Times Cited: 10
Approach of resource expenditure estimation toward mechanization in the manufacturing of cell-based products
Manabu Mizutani, Kentaro Nakajima, Masahiro Kino‐oka
Regenerative Therapy (2022) Vol. 20, pp. 9-17
Open Access | Times Cited: 6
GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration
Martina Kropp, Nina Harmening, Thais Bascuas, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2777-2777
Open Access | Times Cited: 6
Comparison of cell viability methods for human mesenchymal/stromal stem cells and human A549 lung carcinoma cells after freeze-thaw stress
Markus Kardorff, Hanns‐Christian Mahler, Jörg Huwyler, et al.
Journal of Pharmacological and Toxicological Methods (2023) Vol. 124, pp. 107474-107474
Closed Access | Times Cited: 3
Cell therapy manufacturing: process analytic technologies needed to achieve flexible, feedback-driven automation
Matthew M. Hewitt, Nuala Trainor, Nicholas Ostrout, et al.
Current Opinion in Biomedical Engineering (2021) Vol. 20, pp. 100358-100358
Closed Access | Times Cited: 6
Cryoprotection in Human Mesenchymal Stromal/Stem Cells: Synergistic Impact of Urea and Glucose
Markus Kardorff, Hanns‐Christian Mahler, Jörg Huwyler, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 112, Iss. 6, pp. 1681-1686
Closed Access | Times Cited: 2
Particulates are everywhere, but are they harmful in cell and gene therapies?
Samuel A. Molina, Stephanie J. Davies, Dalip Sethi, et al.
Cytotherapy (2022) Vol. 24, Iss. 12, pp. 1195-1200
Closed Access | Times Cited: 3
Approach of design for air mass balance in an aseptic processing area for cell-based products
Shunpei Furomitsu, Manabu Mizutani, Masahiro Kino‐oka
Regenerative Therapy (2024) Vol. 28, pp. 20-29
Closed Access
Advancing Cell and Gene Therapeutic Products for Health Impact – Progress on Pharmaceutical Research, Development, Manufacturing and Controls
Annette Bak, Rodney J. Y. Ho
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 5, pp. 1869-1870
Open Access | Times Cited: 2
Advanced Formulation Approaches for Emerging Therapeutic Technologies
Nour Allahham, Ines Colic, Melissa Rayner, et al.
Handbook of experimental pharmacology (2023), pp. 343-365
Closed Access
Page 1

Scroll to top